\-\ Texto\\:\\ \ \(0\)\
\-\ none\ \(204\)\
\-\ round\\ calcific\\ body\\ at\\ insertion\\ of\\ supraspinatous\\ tendon\\ measuring\\ 8mm\\.\\ \\ second\\ round\\ calcific\\ density\\ proximal\\ diaphysis\\ of\\ humerus\\ near\\ insertion\\ of\\ pectoralis\\ muscle\\.\ \(0\)\
\-\ hydroxyapatite\\ crystal\\ deposition\\ disease\ \(5\)\
\-\ calcium\\ hydroxyapatite\\ crystal\\ deposition\\ disease\\(hadd\\)\\,\\ gout\\,\\ cppd\\,\\ tumoral\\ calcinosis\\,\\ metastatic\\ calcification\\,\\ collagen\\ vascular\\ disease\ \(0\)\
\-\ 53\\ yo\\ female\\ with\\ left\\ shoulder\\ pain\ \(0\)\
\-\ this\\ most\\ likely\\ represents\\ a\\ case\\ of\\ calcific\\ tendonitis\\ caused\\ by\\ calcium\\ hydroxyapatite\\ crystal\\ deposition\\ disease\\.\\ \\ no\\ history\\ of\\ metabolic\\ disease\\ or\\ arthritis\\ was\\ given\\.\\ \\ \ \(0\)\
\-\ hadd\\ is\\ a\\ common\\ idiopathic\\ disorder\\ that\\ occurs\\ in\\ up\\ to\\ 3\\%\\ of\\ adults\\ between\\ 40\\-70\\ years\\ of\\ age\\ and\\ affects\\ both\\ men\\ and\\ women\\.\\ \\ patients\\ may\\ be\\ asymptomatic\\ or\\ present\\ with\\ shoulder\\ pain\\ as\\ in\\ this\\ case\\.\\ \\ \\ \\ hadd\\ account\\ for\\ about\\ 7\\%\\ of\\ painful\\ shoulder\\ syndromes\\.\ \(0\)\
\-\ radiologic\\ features\\ include\\ periarticular\\ calcification\\ that\\ appear\\ cloud\\ like\\ and\\ poorly\\ defined\\.\\ \\ the\\ deposits\\ may\\ become\\ denser\\ or\\ disappear\\.\\ \\ they\\ may\\ cause\\ adjacent\\ periosteal\\ reaction\\,\\ sclerosis\\,\\ erosions\\,\\ or\\ \\ cystic\\ changes\\ in\\ bone\\.\\ \\ \ \(0\)\
\-\ hadd\\ most\\ commonly\\ occurs\\ in\\ the\\ humerus\\ and\\ femur\\ and\\ most\\ commonly\\ at\\ the\\ \\ juxtaarticular\\ and\\ diaphyseal\\ locations\\.\\ \\ other\\ locations\\ may\\ be\\ affected\\.\\ \\ in\\ this\\ case\\ calcification\\ was\\ seen\\ in\\ the\\ supraspinatous\\ and\\ pectoralis\\ major\\ tendons\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hadd\\:\\ 0\\.37930030898922085\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.26499163640741885\ \(0\)\
\-\ crystal\\:\\ 0\\.24308109580379625\ \(0\)\
\-\ calcific\\:\\ 0\\.2172129293430566\ \(0\)\
\-\ deposition\\:\\ 0\\.20803929470190777\ \(0\)\
\-\ supraspinatous\\:\\ 0\\.19336497077784437\ \(0\)\
\-\ pectoralis\\:\\ 0\\.16972835442141182\ \(0\)\
\-\ shoulder\\:\\ 0\\.1601775843705077\ \(0\)\
\-\ calcification\\:\\ 0\\.1472182660399965\ \(0\)\
\-\ disease\\:\\ 0\\.14425962697798914\ \(0\)\
\-\ locations\\:\\ 0\\.143760689043061\ \(0\)\
\-\ may\\:\\ 0\\.13835566842312275\ \(0\)\
\-\ insertion\\:\\ 0\\.1348596259516089\ \(0\)\
\-\ humerus\\:\\ 0\\.12976737165321725\ \(0\)\
\-\ calcium\\:\\ 0\\.12416149893649622\ \(0\)\
\-\ round\\:\\ 0\\.11263695670340226\ \(0\)\
\-\ occurs\\:\\ 0\\.10838460278934604\ \(0\)\
\-\ of\\:\\ 0\\.10760689739465451\ \(0\)\
\-\ most\\:\\ 0\\.10731314742652222\ \(0\)\
\-\ case\\:\\ 0\\.1035930464808588\ \(0\)\
\-\ in\\:\\ 0\\.10259214069153957\ \(0\)\
\-\ commonly\\:\\ 0\\.10171913634595399\ \(0\)\
\-\ cloud\\:\\ 0\\.10156805705027104\ \(0\)\
\-\ and\\:\\ 0\\.0994207050953034\ \(0\)\
\-\ juxtaarticular\\:\\ 0\\.09887933294328174\ \(0\)\
\-\ or\\:\\ 0\\.09564478845721028\ \(0\)\
\-\ disappear\\:\\ 0\\.09321611713048848\ \(0\)\
\-\ denser\\:\\ 0\\.09179691372757331\ \(0\)\
\-\ calcinosis\\:\\ 0\\.09052739302349917\ \(0\)\
\-\ tendonitis\\:\\ 0\\.08736608668714464\ \(0\)\
\-\ tumoral\\:\\ 0\\.08647313732752264\ \(0\)\
\-\ 8mm\\:\\ 0\\.0841336928153696\ \(0\)\
\-\ diaphyseal\\:\\ 0\\.0821754531037166\ \(0\)\
\-\ periarticular\\:\\ 0\\.08102703193459874\ \(0\)\
\-\ deposits\\:\\ 0\\.07812119740774007\ \(0\)\
\-\ cppd\\:\\ 0\\.07614146027324989\ \(0\)\
\-\ tendons\\:\\ 0\\.0741285751060132\ \(0\)\
\-\ this\\:\\ 0\\.0708543129074386\ \(0\)\
\-\ syndromes\\:\\ 0\\.0706622068475795\ \(0\)\
\-\ affects\\:\\ 0\\.07043268938803068\ \(0\)\
\-\ men\\:\\ 0\\.06998636790782686\ \(0\)\
\-\ account\\:\\ 0\\.06998636790782686\ \(0\)\
\-\ collagen\\:\\ 0\\.0697692574879575\ \(0\)\
\-\ gout\\:\\ 0\\.0693464315673026\ \(0\)\
\-\ erosions\\:\\ 0\\.06893794152258516\ \(0\)\
\-\ diaphysis\\:\\ 0\\.06690961842587717\ \(0\)\
\-\ 53\\:\\ 0\\.0643231520950336\ \(0\)\
\-\ adults\\:\\ 0\\.06418700033787739\ \(0\)\
\-\ radiologic\\:\\ 0\\.0640523698612363\ \(0\)\
\-\ metabolic\\:\\ 0\\.062310266927796926\ \(0\)\
\-\ poorly\\:\\ 0\\.06208074946824811\ \(0\)\
\-\ women\\:\\ 0\\.06185552230687675\ \(0\)\
\-\ represents\\:\\ 0\\.06141731756817492\ \(0\)\
\-\ become\\:\\ 0\\.06099449164752002\ \(0\)\
\-\ painful\\:\\ 0\\.06078851565225699\ \(0\)\
\-\ periosteal\\:\\ 0\\.06048600681892644\ \(0\)\
\-\ major\\:\\ 0\\.060094125050172836\ \(0\)\
\-\ tendon\\:\\ 0\\.05999811416525977\ \(0\)\
\-\ that\\:\\ 0\\.05965561348537618\ \(0\)\
\-\ reaction\\:\\ 0\\.05847312165168977\ \(0\)\
\-\ idiopathic\\:\\ 0\\.058140706023642776\ \(0\)\
\-\ disorder\\:\\ 0\\.058140706023642776\ \(0\)\
\-\ affected\\:\\ 0\\.05653174590682605\ \(0\)\
\-\ femur\\:\\ 0\\.056389148949032575\ \(0\)\
\-\ near\\:\\ 0\\.055971212175251035\ \(0\)\
\-\ arthritis\\:\\ 0\\.05590294399090812\ \(0\)\
\-\ be\\:\\ 0\\.05576495106429812\ \(0\)\
\-\ features\\:\\ 0\\.055305335453762525\ \(0\)\
\-\ caused\\:\\ 0\\.0551125425039109\ \(0\)\
\-\ the\\:\\ 0\\.05485937856133413\ \(0\)\
\-\ appear\\:\\ 0\\.054133380483600835\ \(0\)\
\-\ measuring\\:\\ 0\\.0531734438642801\ \(0\)\
\-\ at\\:\\ 0\\.05192310514042311\ \(0\)\
\-\ second\\:\\ 0\\.051456417531575635\ \(0\)\
\-\ about\\:\\ 0\\.051456417531575635\ \(0\)\
\-\ like\\:\\ 0\\.051085640513902165\ \(0\)\
\-\ pain\\:\\ 0\\.04919082636535348\ \(0\)\
\-\ they\\:\\ 0\\.049111436928213764\ \(0\)\
\-\ defined\\:\\ 0\\.04903419754638978\ \(0\)\
\-\ sclerosis\\:\\ 0\\.048957450138487874\ \(0\)\
\-\ muscle\\:\\ 0\\.0488054064516303\ \(0\)\
\-\ was\\:\\ 0\\.047908683336702514\ \(0\)\
\-\ given\\:\\ 0\\.047281734713506274\ \(0\)\
\-\ cause\\:\\ 0\\.046824524762182795\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04679252128439362\ \(0\)\
\-\ density\\:\\ 0\\.04557745717684554\ \(0\)\
\-\ vascular\\:\\ 0\\.045376869628682974\ \(0\)\
\-\ body\\:\\ 0\\.04523561007055833\ \(0\)\
\-\ between\\:\\ 0\\.04465976591468184\ \(0\)\
\-\ adjacent\\:\\ 0\\.04455313422493474\ \(0\)\
\-\ age\\:\\ 0\\.04315163736790113\ \(0\)\
\-\ proximal\\:\\ 0\\.04294085702556326\ \(0\)\
\-\ yo\\:\\ 0\\.04294085702556326\ \(0\)\
\-\ years\\:\\ 0\\.04213277983750821\ \(0\)\
\-\ changes\\:\\ 0\\.04153972435257581\ \(0\)\
\-\ cystic\\:\\ 0\\.04139591170570254\ \(0\)\
\-\ likely\\:\\ 0\\.041073503111772776\ \(0\)\
\-\ include\\:\\ 0\\.04089586890246939\ \(0\)\
\-\ common\\:\\ 0\\.03897982657067648\ \(0\)\
\-\ patients\\:\\ 0\\.03866641157907451\ \(0\)\
\-\ both\\:\\ 0\\.03832923388427459\ \(0\)\
\-\ metastatic\\:\\ 0\\.0376969437334846\ \(0\)\
\-\ none\\:\\ 0\\.03756248019208558\ \(0\)\
\-\ bone\\:\\ 0\\.037503196912329125\ \(0\)\
\-\ other\\:\\ 0\\.0356944643358086\ \(0\)\
\-\ present\\:\\ 0\\.03526944488102227\ \(0\)\
\-\ up\\:\\ 0\\.03399992417694812\ \(0\)\
\-\ female\\:\\ 0\\.03316713438094536\ \(0\)\
\-\ seen\\:\\ 0\\.03235922448351346\ \(0\)\
\-\ by\\:\\ 0\\.029188274847481283\ \(0\)\
\-\ as\\:\\ 0\\.027612728315699338\ \(0\)\
\-\ with\\:\\ 0\\.02691779812255163\ \(0\)\
\-\ history\\:\\ 0\\.0262602159633154\ \(0\)\
\-\ left\\:\\ 0\\.023446531580524038\ \(0\)\
\-\ no\\:\\ 0\\.02235138608761538\ \(0\)\
\-\ for\\:\\ 0\\.02083262802033089\ \(0\)\
\-\ is\\:\\ 0\\.018823164573249944\ \(0\)\
\-\ to\\:\\ 0\\.017183266115489267\ \(0\)\
